TetraLogic Pharmaceuticals Corp - ESG Rating & Company Profile powered by AI
The Disclosure score includes 17 United Nations SDGs including: 'Zero Hunger', 'Climate Action' and 'Partnerships for the Goals'. Check the end of this webpage for potential risks for TetraLogic Pharmaceuticals Corp based on industry, geography and size. Alternative corporations in the scoring peer group for TetraLogic Pharmaceuticals Corp are shownin the table.
TetraLogic Pharmaceuticals Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | TetraLogic Pharmaceuticals Corp | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does TetraLogic Pharmaceuticals Corp have an accelerator or VC vehicle to help deliver innovation?
Does TetraLogic Pharmaceuticals Corp disclose current and historical energy intensity?
Does TetraLogic Pharmaceuticals Corp report the average age of the workforce?
Does TetraLogic Pharmaceuticals Corp reference operational or capital allocation in relation to climate change?
Does TetraLogic Pharmaceuticals Corp disclose its ethnicity pay gap?
Does TetraLogic Pharmaceuticals Corp disclose cybersecurity risks?
Does TetraLogic Pharmaceuticals Corp offer flexible work?
Does TetraLogic Pharmaceuticals Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does TetraLogic Pharmaceuticals Corp disclose the number of employees in R&D functions?
Does TetraLogic Pharmaceuticals Corp conduct supply chain audits?
Does TetraLogic Pharmaceuticals Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does TetraLogic Pharmaceuticals Corp conduct 360 degree staff reviews?
Does TetraLogic Pharmaceuticals Corp disclose the individual responsible for D&I?
Does TetraLogic Pharmaceuticals Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does TetraLogic Pharmaceuticals Corp disclose current and / or historical scope 2 emissions?
Does TetraLogic Pharmaceuticals Corp disclose water use targets?
Does TetraLogic Pharmaceuticals Corp have careers partnerships with academic institutions?
Did TetraLogic Pharmaceuticals Corp have a product recall in the last two years?
Does TetraLogic Pharmaceuticals Corp disclose incidents of discrimination?
Does TetraLogic Pharmaceuticals Corp allow for Work Councils/Collective Agreements to be formed?
Has TetraLogic Pharmaceuticals Corp issued a profit warning in the past 24 months?
Does TetraLogic Pharmaceuticals Corp disclose parental leave metrics?
Does TetraLogic Pharmaceuticals Corp disclose climate scenario or pathway analysis?
Does TetraLogic Pharmaceuticals Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does TetraLogic Pharmaceuticals Corp disclose the pay ratio of women to men?
Does TetraLogic Pharmaceuticals Corp support suppliers with sustainability related research and development?
Does TetraLogic Pharmaceuticals Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does TetraLogic Pharmaceuticals Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is TetraLogic Pharmaceuticals Corp involved in embryonic stem cell research?
Does TetraLogic Pharmaceuticals Corp disclose GHG and Air Emissions intensity?
Does TetraLogic Pharmaceuticals Corp disclose its waste policy?
Does TetraLogic Pharmaceuticals Corp report according to TCFD requirements?
Does TetraLogic Pharmaceuticals Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does TetraLogic Pharmaceuticals Corp disclose energy use targets?
Does TetraLogic Pharmaceuticals Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does TetraLogic Pharmaceuticals Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for TetraLogic Pharmaceuticals Corp
These potential risks are based on the size, segment and geographies of the company.
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.